Cargando…

Mortality Risk Assessment Using CHA(2)DS(2)-VASc Scores in Patients Hospitalized With Coronavirus Disease 2019 Infection

Early risk stratification for complications and death related to Coronavirus disease 2019 (COVID-19) infection is needed. Because many patients with COVID-19 who developed acute respiratory distress syndrome have diffuse alveolar inflammatory damage associated with microvessel thrombosis, we aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruocco, Gaetano, McCullough, Peter A., Tecson, Kristen M., Mancone, Massimo, De Ferrari, Gaetano M., D'Ascenzo, Fabrizio, De Rosa, Francesco G., Paggi, Anita, Forleo, Giovanni, Secco, Gioel G., Pistis, Gianfranco, Monticone, Silvia, Vicenzi, Marco, Rota, Irene, Blasi, Francesco, Pugliese, Francesco, Fedele, Francesco, Palazzuoli, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521434/ https://www.ncbi.nlm.nih.gov/pubmed/32991860 http://dx.doi.org/10.1016/j.amjcard.2020.09.029

Ejemplares similares

Usefulness of Combined Renin-Angiotensin System Inhibitors and Diuretic Treatment In Patients Hospitalized with COVID-19
por: Palazzuoli, Alberto, et al.
Publicado: (2022)

Antecedent Administration of Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID‐19 Syndrome
por: Palazzuoli, Alberto, et al.
Publicado: (2020)

Inpatient Mortality According to Level of Respiratory Support Received for Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Infection: A Prospective Multicenter Study
por: Palazzuoli, Alberto, et al.
Publicado: (2020)

Screening, detection, and management of heart failure in the SARS-CoV2 (COVID-19) pandemic
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

CHA(2)DS(2)-VASc: time to settle the score?
por: Kaplan, Rachel M., et al.
Publicado: (2022)

Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties
por: Schiavone, Marco, et al.
Publicado: (2020)

Effects of Metolazone Administration on Congestion, Diuretic Response and Renal Function in Patients with Advanced Heart Failure
por: Palazzuoli, Alberto, et al.
Publicado: (2021)

CHA(2)DS(2)-VASc and R(2)-CHA(2)DS(2)-VASc scores predict in-hospital and post-discharge outcome in patients with myocardial infarction
por: Węgiel, Michał, et al.
Publicado: (2018)

Atrial fibrillation in patients with COVID-19. Usefulness of the CHA(2)DS(2)-VASc score: an analysis of the international HOPE COVID-19 registry
por: Uribarri, Aitor, et al.
Publicado: (2021)

CHA(2)DS(2)-Vasc score and CHA(2)DS(2)-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents
por: Zhao, Sheng Gang, et al.
Publicado: (2019)

CHA2DS2-VASc score and modified CHA2DS2-VASc score can predict mortality and intensive care unit hospitalization in COVID-19 patients
por: Gunduz, Ramazan, et al.
Publicado: (2021)

Heart failure: a weak link in CHA(2)DS(2)‐VASc
por: Friberg, Leif, et al.
Publicado: (2018)

CHA(2)DS(2)-VASc Score in Cardio-Oncology: Sharpening the Rules
por: López-Fernández, Teresa
Publicado: (2023)

Loop diuretics in acute heart failure: beyond the decongestive relief for the kidney
por: Palazzuoli, Alberto, et al.
Publicado: (2015)

Risk Stratification Using the CHA(2)DS(2)‐VASc Score in Takotsubo Syndrome: Data From the Takotsubo Italian Network
por: Parodi, Guido, et al.
Publicado: (2017)

Predictive value of CHA(2)DS(2)-VASc and CHA(2)DS(2)-VASc-HS scores for failed reperfusion after thrombolytic therapy in patients with ST-segment elevation myocardial infarction
por: Kilic, Salih, et al.
Publicado: (2019)

Cheating the CHA(2)DS(2)-VASc Score: Thromboembolism in Apical Hypertrophic Cardiomyopathy
por: Weir, Robin A. P., et al.
Publicado: (2014)

Correlation between CHA(2)DS(2)-VASc Score and Glaucoma Treatment and Prognosis
por: Pikkel, Yoav Y., et al.
Publicado: (2018)

Beyond CHA(2)DS(2)-VASc in atrial fibrillation: the atrium and the risk of stroke
por: Boccanelli, Alessandro
Publicado: (2020)

Escore CHA2DS2-VASc: O Que Mais Podemos Predizer?
por: Maia, Adnaldo da Silveira
Publicado: (2023)

Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA(2)DS(2)VASC score: CCHA(2)DS(2)VASC score
por: Bungo, Brandon, et al.
Publicado: (2022)

Total Adiponectin Is Inversely Associated with Platelet Activation and CHA(2)DS(2)-VASc Score in Anticoagulated Patients with Atrial Fibrillation
por: Carnevale, Roberto, et al.
Publicado: (2014)

Value of the CHA(2)DS(2)‐VASc score for predicting outcome in patients with heart failure
por: Shuvy, Mony, et al.
Publicado: (2020)

Coronary Embolism despite CHA₂DS₂-VASc Score of Zero: Should We Reconsider Anticoagulation?
por: Ahmed, Ammar, et al.
Publicado: (2021)

Does CHA2DS2-VASc score predict mortality in chronic kidney disease?
por: Goudis, Christos, et al.
Publicado: (2021)

Stroke and systemic embolism risk in patients with CHA(2)DS(2)‐VASc score of 0
por: Babayiğit, Erdi, et al.
Publicado: (2023)

Prognostic Impacts of CHADS(2), CHA(2)DS(2)-VASc, and CHA(2)DS(2)-VASc-HS Scores on Clinical Outcomes After Elective Drug-Eluting Stent Placement for De Novo Coronary Stenosis
por: Ukaji, Tomoaki, et al.
Publicado: (2023)

Fibrilación auricular en pacientes con COVID-19. Utilidad de la puntuación CHA(2)DS(2)-VASc: un análisis del registro internacional HOPE COVID-19
por: Uribarri, Aitor, et al.
Publicado: (2021)

High CHA(2)DS(2)-VASc score without atrial fibrillation: ‘NAO yes, NAO no’
por: Perna, Gian Piero
Publicado: (2019)

What should the C (‘congestive heart failure’) represent in the CHA(2)DS(2)‐VASc score?
por: Mulder, Bart A., et al.
Publicado: (2020)

CHA(2)DS(2)‐VASc Score and the Risk of Ventricular Tachyarrhythmic Events and Mortality in MADIT‐CRT
por: Nof, Eyal, et al.
Publicado: (2019)

CHA(2)DS(2)-VASc score stratifies mortality risk in patients with and without atrial fibrillation
por: Harb, Serge C, et al.
Publicado: (2021)

Predictive Value of CHA(2)DS(2) -VASc-HSF Score for Severity of Acute Coronary Syndrome
por: Liu, Jingyi, et al.
Publicado: (2022)

CHA(2)DS(2)-VASc score for in-hospital recurrence risk stratification in patients with myocardial infarction
por: Pang, Hui, et al.
Publicado: (2022)

CHA2DS2‐VASc score predicts atrial fibrillation recurrence after cardioversion: Systematic review and individual patient pooled meta‐analysis
por: Vitali, Francesco, et al.
Publicado: (2019)

The CHA(2)DS(2)‐VASc score as a predictor of high mortality in hospitalized heart failure patients
por: Yoshihisa, Akiomi, et al.
Publicado: (2016)

Association between modified CHA(2)DS(2)-VASc Score with Ankle-Brachial index < 0.9
por: Hsu, Po-Chao, et al.
Publicado: (2018)

Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA(2)DS(2)-VASc score
por: Yan, Shuangbing, et al.
Publicado: (2019)

The association of CHA(2)DS(2)-VASc score and carotid plaque in patients with non-valvular atrial fibrillation
por: Shang, Luxiang, et al.
Publicado: (2019)

Predicting stroke and death in patients with heart failure using CHA(2)DS(2)-VASc score in Asia
por: Son, Mi Kyoung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tigrtrsf4ddrfni3303sm7iuil